Legal Battle Over Abortion Drug Access
Louisiana sued FDA to roll back mifepristone rules, claiming state bans are undermined.
5th Circuit Court suspended mail access and telehealth for mifepristone.
Abortion opponents challenged mifepristone safety for 25+ years.
Pharmaceutical companies and Democrats warned Supreme Court against limiting access.
Trump administration did not file brief on mifepristone regulations.
Supreme Court reviews mifepristone access four years after overturning Roe v. Wade.
2 weeks ago